Company page
Passage Bio, Inc.
Passage Bio, Inc. is a public company traded under the ticker PASG in the American market. The company has a market capitalization of approximately $17.93 million. Passage Bio focuses on developing genetic medicines for rare diseases, leveraging its expertise in gene therapy.
- Ticker
- PASG:NASDAQ
- Asset type
- Stock
- Market cap
- $17.9M
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD